Cryptocurrency exchanges Binance has been experiencing temporary service issues today due to a network interruption at Amazon (NASDAQ:AMZN) Web Services (AWS) data center. Binance has acknowledged the ...

Barclays (LON:BARC) has upgraded JD Sports Fashion plc (LON:JD) to ‘equal weight’ from ‘underweight’, citing improved capital allocation and a more balanced risk-reward profile, in a note dated ...

Investing.com -- Shares of Theon declined by 3.5% as the company published its annual report for FY24, which was in line with preliminary results announced on February 14. Despite a significant ...

U.S. stock index futures edged higher Tuesday, but sentiment remained fragile as investors awaited more corporate earnings amid uncertainty over Trump’s tariffs. Dow Jones Futures rose 81 points, or 0 ...

The activity was tilted toward exchange-traded funds (ETFs), with single stocks seeing net selling. “Clients bought stocks across all three size segments for a second consecutive week,” BofA ...

The Financial Conduct Authority (FCA) of Britain has, for the first time, appointed staff in the United States and the Asia-Pacific region. This move is aimed at assisting overseas companies to enter ...

In anticipation of Albemarle’s first-quarter earnings report due on May 1, Citi has made downward adjustments to their price assumptions for Albemarle. The firm now projects a realized lithium ...

Investing.com -- Goldman Sachs (NYSE: GS) has upgraded UK fashion retailer Next (LON: NXT) to “buy” from “neutral,” raising its 12-month price target to 14,000p from 12,200p. The brokerage cites ...

Goldman Sachs Group Inc, JPMorgan Chase & Co, Morgan Stanley, iShares Transportation Average ETF. Read 's Market Analysis on Investing.com AU.

Citigroup (NYSE: C) joined a string of brokerages, including Goldman Sachs (NYSE: GS) and BofA, in slashing its S&P 500 target below the 6000 mark, with the bank’s year-end target now at 5800, ...

Tate & Lyle (LON: TATE), the UK-based food and beverage ingredient supplier, on Tuesday confirmed that its FY25 results for the core business are in line with the ...

Despite the strong Q2, Carl Zeiss Meditec maintained its FY2025 guidance, citing macroeconomic and geopolitical risks, including potential U.S. tariffs and currency volatility. The company continues ...